No overview information available.
No background information available.
用于胆石症、胆囊炎、胆道运动障碍、胆囊术后综合征及慢性胰腺炎等。
No associated conditions information available.
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found for this drug
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
---|
No FDA products found for this drug
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
---|
No EMA products found for this drug
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
---|
No HSA products found for this drug
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
---|---|---|---|---|---|---|---|---|---|
国药准字H36021937 | 片剂 | N/A | 40mg | Chemical Drug | Approved | 2021/09/23 | Domestic | ||
国药准字H14023394 | 片剂 | N/A | 40mg | Chemical Drug | Approved | 2020/07/22 | Domestic | ||
国药准字H45021170 | 片剂 | N/A | 40mg | Chemical Drug | Approved | 2020/08/24 | Domestic | ||
国药准字H15021280 | N/A | N/A | 40mg | Chemical Drug | Approved | 2003/03/25 | Domestic | ||
国药准字H32026053 | 片剂 | N/A | 40mg | Chemical Drug | Approved | 2015/09/16 | Domestic | ||
国药准字H37023663 | 片剂 | N/A | 40mg | Chemical Drug | Approved | 2020/04/03 | Domestic | ||
国药准字H33022366 | 片剂 | N/A | 40mg | Chemical Drug | Approved | 2020/04/09 | Domestic | ||
国药准字H65020350 | 片剂 | N/A | 40mg | Chemical Drug | Approved | 2022/07/19 | Domestic | ||
国药准字H13024248 | 片剂 | N/A | 40mg | Chemical Drug | Approved | 2020/09/28 | Domestic | ||
国药准字H13024345 | 片剂 | N/A | 40mg | Chemical Drug | Approved | 2020/09/20 | Domestic |
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
---|
No PPB products found for this drug
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
---|
No TGA products found for this drug